A carregar...
Are there benefits to starting HAART during primary HIVinfection? Conclusions from the Seattle Primary Infection Cohort vary by control group
BACKGROUND: It is controversial whether starting highly active antiretroviral therapy (HAART) during primary HIV infection (PHI) is beneficial. METHODS: Subjects in this observational cohort began HAART <30 days (group 1: acute treatment, n=40), 31–180 days (group 2: early treatment, n=82), or &g...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3410712/ https://ncbi.nlm.nih.gov/pubmed/22581875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1258/ijsa.2011.011178 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|